Stockholders Equity (Details)				1 Months Ended	4 Months Ended	9 Months Ended
	Nov. 02, 2016 USD ($) shares	Aug. 24, 2015 USD ($) shares	Mar. 13, 2015 USD ($)	Mar. 31, 2015 USD ($)	Dec. 31, 2015 USD ($) $ / shares shares	Sep. 30, 2016 $ / shares shares	Sep. 30, 2015 USD ($)
Preferred Stock
Preferred stock, shares authorized					25,000,000	25,000,000
Preferred stock, par value (in dollars per share) | $ / shares					$ 0.0001	$ 0.0001
Preferred stock, shares issued					0	0
Preferred stock, shares outstanding					0	0
Conversion of convertible notes to common stock | $							$ 2,080,292
Preferred dividend (as a percent)						8.00%
Common Stock
Common stock, shares authorized					100,000,000	100,000,000
Common stock, par value (in dollars per share) | $ / shares					$ 0.0001	$ 0.0001
Common stock, shares issued					24,769,083	24,769,083
Common stock, shares outstanding					24,769,083	24,769,083
Option period for stock purchase		30 months
Guggenheim
Common Stock
Maximum potential consideration | $			$ 25,000,000
Common stock | LPC
Common Stock
Maximum potential consideration | $		$ 17,000,000
Stock issued as consideration (in shares)		103,364			105,379
Incremental potential consideration | $		$ 15,000,000
Stock issued per purchase as consideration (in shares)		34,455
Shares allowed per transaction (in shares)		100,000
Maximum shares allowed per transaction (in shares)		175,000
Maximum amount that can be received per transaction | $		$ 1,000,000
Stock issued (in shares)					1,435,612
Gross proceeds from shares sold | $					$ 2,900,000
8.00% Convertible Notes Due 2019
Preferred Stock
Conversion of convertible notes to common stock | $				$ 3,250,000
Conversion of debt, initial conversion ratio						148.3019
8.00% Convertible Notes Due 2019 | Medivir
Preferred Stock
Debt holders (as a percent)	100.00%
Conversion of convertible notes to common stock | $	$ 2,200,000
Stock issued upon conversion (in shares)	12,222,222
Conversion of debt, initial conversion ratio						1